Keyword,Sentence,Notes
637879861,"Allele G is associated with increased risk of adverse events when treated with methotrexate in people with Arthritis, Rheumatoid as compared to allele A.",
637879888,Genotype GG is associated with decreased overall survival when treated with fluorouracil in people with Stomach Neoplasms as compared to genotypes CC + CG.,"This G/C snp is in TP53 which is on the minus strand, presenting the opportunity for the alleles to be easily confused. The C>G change in the gene is represented by a G>C change on the positive chromosomal strand."
655386216,"Allele T is associated with increased risk of non-response when treated with Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele C.","54 subjects were treated with etanercept, 37 with infliximab, and 25 with adalimumab. Response ascertained by change in Disease Activity Score (DAS28) observed after 14 wks."
655386219,"Allele T is associated with increased risk of non-response when treated with Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele C.","Authors state borderline significance. 54 subjects were treated with etanercept, 37 with infliximab, and 25 with adalimumab. Response to therapy was determined by the change in Disease Activity Score (DAS28) observed after 14 wks."
655386250,"Allele C is associated with increased risk of non-response when treated with Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele T.","54 subjects were treated with etanercept, 37 with infliximab, and 25 with adalimumab. Authors state borderline significance."
655386347,"Allele T is associated with increased risk of non-response when treated with Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele C.","54 were treated with etanercept, 37 with infliximab, and 25 with adalimumab. Response to therapy was determined by the change in Disease Activity Score (DAS28) observed after 14 wks."
655386350,"Allele A is associated with increased risk of non-response when treated with Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele G.","54 subjects were treated with etanercept, 37 with infliximab, and 25 with adalimumab. Response to therapy was determined by the change in Disease Activity Score (DAS28) observed after 14 wks."
655386353,"Allele A is associated with increased risk of non-response when treated with Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele C.","54 subjects were treated with etanercept, 37 with infliximab, and 25 with adalimumab. Response to therapy was determined by the change in Disease Activity Score (DAS28) observed after 14 wks."
655386356,"Allele A is associated with increased risk of non-response when treated with Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele G.","54 subjects were treated with etanercept, 37 with infliximab, and 25 with adalimumab. Response to therapy was determined by the change in Disease Activity Score (DAS28) observed after 14 wks."
655386363,"Allele T is associated with increased risk of non-response when treated with Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele G.","54 subjects were treated with etanercept, 37 with infliximab, and 25 with adalimumab. Response to therapy was determined by the change in Disease Activity Score (DAS28) observed after 14 wks."
655386373,"Allele C is associated with increased risk of non-response when treated with Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele T.","54 subjects were treated with etanercept, 37 with infliximab, and 25 with adalimumab. Response to therapy was determined by the change in Disease Activity Score (DAS28) observed after 14 wks."
981476219,"Allele A is associated with increased risk of Hepatitis, Toxic when treated with ethambutol, isoniazid, pyrazinamide and rifampin in people with Tuberculosis as compared to allele G.",The frequency of allele A was significantly different between patients with and without drug-induced hepatitis. Described as the *7 allele.
655386377,"Allele T is associated with increased risk of non-response when treated with Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele G.","54 subjects were treated with etanercept, 37 with infliximab, and 25 with adalimumab. Response to therapy was determined by the change in Disease Activity Score (DAS28) observed after 14 wks."
652351416,Genotype AA is associated with decreased risk of cardiac events when treated with perindopril in people with Coronary Artery Disease as compared to genotypes GG + AG.,
652252614,Genotype TT is associated with decreased risk of cardiac events when treated with perindopril in people with Coronary Artery Disease as compared to genotypes AA + TA.,
652326097,Genotype TT is associated with decreased risk of cardiac events when treated with perindopril in people with Coronary Artery Disease as compared to genotypes CC + CT.,
655387557,Genotype CC is associated with increased risk of cardiac damage when treated with anthracyclines and related substances in people with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotypes TT + CT.,
655387546,Allele G is associated with increased risk of Heart Failure when treated with anthracyclines and related substances as compared to allele A.,
699642233,Allele G is associated with decreased tumor response when treated with doxorubicin in people with Breast Neoplasms as compared to genotype AA.,
655386684,Genotype CC is associated with increased likelihood of Muscular Diseases when treated with simvastatin in people with Myocardial Infarction as compared to genotype TT.,The increased risk is for myopathy. CC > CT> TT. 40 mg /day simvastatin. RR below is per copy of C allele.
655386692,Genotype CC is associated with increased risk of Muscular Diseases when treated with simvastatin as compared to genotype CT.,The increased risk is for myopathy. CC > CT> TT. 40 mg /day simvastatin. RR below is per copy of C allele.
655386696,Genotype CT is associated with increased risk of Muscular Diseases when treated with simvastatin as compared to genotype TT.,The increased risk is for myopathy. CC > CT> TT. 40 mg /day simvastatin. RR below is per copy of C allele.
699642404,"Allele A is associated with decreased likelihood of treatment-emergent suicidality when treated with citalopram in people with Depressive Disorder, Major as compared to allele G.",
699642415,"Genotype GG is associated with increased likelihood of remission when treated with antidepressants in people with Depressive Disorder, Major as compared to genotypes AA + AG.",
655386898,"Allele A is associated with increased risk of cardiovascular death, myocardial infarction, or stroke when treated with clopidogrel in people with Acute coronary syndrome as compared to allele G.",(significance stated as per loss-of function CYP2C19 alleles)
655388276,Allele A is associated with increased risk of cardiovascular event when treated with clopidogrel in people with Myocardial Infarction as compared to allele C.,(significance measured as per two CYP2C19 loss of function alleles)
769146008,Allele A is associated with increased risk of Death when treated with clopidogrel in people with Acute coronary syndrome as compared to allele G.,"Death from cardiovascular causes, myocardial infarction, or stroke. Significance measured as per carrying at least one CYP2C19 reduced-function allele. CYP2C19 Genotyping Results in Clopidogrel Allocated Subjects: Intermediate metabolizer (N=357) -*1A/*2A, *1A/*3, *1A/*4, *1A/*8; Poor metabolizer (N=38) *2A/*2A, *2A/*3, *2A/*4, *2A/*5A, *2A/*8. The *2 allele (rs4244285) accounted for 95% of the subjects who were classified as carriers of a reduced-function allele. Carriers of a *2 allele (rs4244285) had a higher rate of the primary efficacy outcome (HR: 1.42; 95% CI, 0.98 to 2.05; P=0.04) and of stent thrombosis (HR: 3.33; 95% CI, 1.28 to 8.62; P=0.004) than did noncarriers."
769146034,Allele A is associated with increased risk of cardiovascular events when treated with clopidogrel in people with percutaneous coronary intervention as compared to allele G.,(significance measured as per carrying at least one CYP2C19 reduced-function allele) The association was determined for cardiovascular ischemic event or death during 1 year of follow-up.
769146043,Allele A is associated with increased risk of ischaemic events when treated with clopidogrel in people with Acute coronary syndrome as compared to allele G.,"The higher rate of ischaemic events was determined during the first 30 days of treatment. The study reports association for CYP2C19 loss-of-function alleles, which includes rs4244285 (CYP2C19*2). Further loss-of-function alleles CYP2C19*3, *4, *5, *6, *7, and *8 were genotyped. In 5148 patients on clopidogrel the CYP2C19 genotypes were following:*1/*1=1862 (36%); *1/*2=898 (17%); *1/*3= 6 (<1%); *1/*4=8 (<1%); *1/*6=2 (<1%); *1/*8=21 (<1%); *2/*2=115 (2%); *2/*4 =3 (<1%); *2/*5=1 (<1%); *2/*8=6 (<1%). However, when the full follow-up period (1 year) was considered, the difference in outcomes between patients with and without any loss-of-function allele was not significant."
655386381,"Allele C is associated with increased risk of non-response when treated with Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele T.","54 subjects were treated with etanercept, 37 with infliximab, and 25 with adalimumab. Response to therapy was determined by the change in Disease Activity Score (DAS28) observed after 14 wks."
655386386,"Allele A is associated with increased risk of non-response when treated with Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele G.","54 subjects were treated with etanercept, 37 with infliximab, and 25 with adalimumab. Response to therapy was determined by the change in Disease Activity Score (DAS28) observed after 14 wks."
655386391,"Allele A is associated with increased risk of non-response when treated with Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele G.","54 subjects were treated with etanercept, 37 with infliximab, and 25 with adalimumab. Response to therapy was determined by the change in Disease Activity Score (DAS28) observed after 14 wks."
613979632,Genotype CC is associated with decreased risk of grade 3 or 4 gastrointestinal toxicity when treated with platinum and taxanes in people with Ovarian Neoplasms.,
637880063,Allele T is associated with increased risk of Ototoxicity when treated with cisplatin in people with Neoplasms as compared to allele C.,
637880083,Genotype AC is associated with decreased risk of nephrotoxicity when treated with cisplatin in people with Neoplasms as compared to genotype CC.,Risk of nephrotoxicity was measured by increase in serum creatinine compared to baseline. Statistics were comparing baseline to after cycle 1. No AA homozygotes were reported.
637880188,Genotype AA is associated with increased severity of Peripheral Nervous System Diseases when treated with oxaliplatin in people with Gastrointestinal Neoplasms as compared to genotypes GG + AG.,
637880175,Genotype GG is associated with increased severity of Neurotoxicity Syndromes when treated with oxaliplatin in people with Colorectal Neoplasms as compared to genotypes AA + AG.,
613979636,Genotype AA is associated with increased risk of hematological toxicity when treated with Platinum compounds and taxanes in people with Ovarian Neoplasms as compared to genotypes GG + AG.,
637880145,"Allele G is associated with decreased risk of Neutropenia when treated with Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to allele A.",
637880107,Genotype AA is associated with increased risk of dying when treated with Platinum compounds in people with Colorectal Neoplasms as compared to genotype GG.,(treated with 5-FU plus oxaliplatin)
637880121,Genotype AA is associated with increased risk of disease progression when treated with Platinum compounds in people with Colorectal Neoplasms as compared to genotype GG.,
655386344,Genotype AA is associated with increased progression free survival when treated with cisplatin and cyclophosphamide in people with Ovarian Neoplasms as compared to genotypes GG + AG.,(Ile/Ile)
637880148,"Allele G is not associated with survival when treated with Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to allele A.",
655386396,Genotypes TT + GT are associated with increased sensitivity when exposed to erlotinib as compared to genotype GG.,Done in NCI-60 cancer cell lines.
655386400,Genotypes TT + GT are associated with decreased sensitivity when treated with topoisomerase I inhibitors as compared to genotype GG.,This was done in NCI-60 cancer cell lines.
655386399,Genotypes TT + GT are associated with decreased sensitivity when exposed to geldanamycin as compared to genotype GG.,Done in NCI-60 cell lines.
655386403,Genotypes TT + GT are associated with decreased sensitivity when exposed to Alkylating Agents as compared to genotype GG.,Done in NCI-60 Cancer cell lines.
655386406,Genotypes GT + TT are associated with increased progression-free survival (PFS) time when treated with gefitinib in advanced non-small-cell lung cancer patients as compared to genotype GG.,
637880231,Allele C is associated with decreased likelihood of non-response when treated with citalopram in people with Depression as compared to allele T.,
637880307,Genotype CC is associated with increased likelihood of remission when treated with antidepressants in people with Depressive Disorder.,
1183689191,CYP2D6 poor metabolizer is not associated with response to propranolol (as measured by percentage reductions in exercise heart rate) when treated with propranolol in healthy individuals as compared to CYP2D6 extensive metabolizer.,
1183689446,CYP1A2 *1C is not associated with differences in plasma OLZ and metabolite concentrations and on their respective ratios when treated with olanzapine in people with Schizophrenia as compared to CYP1A2 *1A.,
637880298,Allele A is associated with increased likelihood of response when treated with citalopram in people with Depression as compared to allele G.,
637880382,Allele A is associated with increased likelihood of response when treated with citalopram in people with Depression as compared to allele G.,
637880402,"Allele A is not associated with increased likelihood of response when treated with Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele G.",
637880422,"Allele A is associated with increased resistance when treated with antidepressants in people with Depressive Disorder, Major as compared to allele G.",Not significant after Bonferroni
637880371,Genotype AA is associated with increased likelihood of response when treated with citalopram in people with Depression as compared to genotype GG.,
637880323,Allele G is associated with increased likelihood of remission when treated with antidepressants in people with Depressive Disorder as compared to allele A.,
981201252,"Genotype TT is associated with increased severity of Neurotoxicity Syndromes when treated with fluorouracil, leucovorin and oxaliplatin in people with Colorectal Neoplasms as compared to genotypes CC + CT.",Authors considered FDR adjusted p value less than 0.1 as significant. Adjusted p value (q value) shown in study parameters.
1184510096,Genotype TT is associated with decreased likelihood of INR >3 (over-anticoagulation) when treated with warfarin as compared to genotypes CC + CT.,"suggesting that patients with the TT genotype were less sensitive to warfarin during induction. However, after adjustment for false discovery rate, none of the findings remained significant at a threshold q value of <0.05."
613976809,Allele C is associated with increased risk of Stevens-Johnson Syndrome when treated with carbamazepine as compared to allele T.,
613977005,Allele G is associated with decreased severity of Hypersensitivity when treated with carbamazepine as compared to allele A.,Allele G was considered protective against severe hypersensitivity. (allele complimented to plus strand)
605833570,Allele A is associated with increased likelihood of nicotine dependence when exposed to nicotine as compared to allele G.,This association was significant after correction in only African American females.
613978953,Genotype CC is associated with decreased likelihood of improved left ventricular ejection fraction when treated with carvedilol in people with Heart Failure as compared to genotypes GG + CG.,
655385753,Allele C is associated with increased risk of Urticaria when treated with aspirin.,
613977087,Allele G is associated with increased risk of Tobacco Use Disorder when exposed to nicotine as compared to allele A.,"There was a significant association of this SNP with the Fagerstrom test of nicotine dependence score, and the association was not independent of rs1044396. This snp is in the UTR-3 region."
655385772,Allele A is associated with increased risk of Torsades de Pointes when treated with amiodarone as compared to allele G.,found in 1 person
655388028,Genotype AA is associated with increased likelihood of progression-free survival when treated with gemcitabine in women with Breast Neoplasms as compared to allele G.,"This must be considered as part of a haplotype. There may be a tendency, though not a statistically significant one, towards better progression-free survival time and overall survival with gemcitabine treatment for the A allele carriers than for patients carrying the G allele along with the A allele at rs1042858."
655388027,Allele G is associated with decreased risk of Neutropenia when treated with gemcitabine in women with Breast Neoplasms as compared to allele A.,"This must be looked at as part of a haplotype. An advanced breast cancer patient with genotype AA who is being treated with gemcitabine may be more likely to experience toxicity such as neutropenia, leukopenia,shorter treatment delay and lower G-CSF requirement than such a patient carrying a haplotype containing the G allele along with the A allele at rs1042858."
655385916,"Genotypes AG + GG are associated with increased likelihood of remission when treated with amitriptyline, citalopram, paroxetine or venlafaxine in people with Depression as compared to genotype AA.",Association was significant after correction for multiple testing at 4 weeks but not at 5 or at 6 weeks.
655386253,"Allele A is associated with increased likelihood of remission when treated with amitriptyline, citalopram, paroxetine or venlafaxine in people with Depression as compared to allele C.","Association was significant after correction for multiple testing at 6 weeks, but not so at 4 weeks. It's not completely clear which allele was associated with remission or which sets of alleles/genotypes were compared. I am entering the minor allele (in European populations) as the associated one."
655386098,Genotype CC is associated with decreased risk of side effects when treated with amodiaquine as compared to genotypes TT + CT.,This is an undetailed review article and the evidence is in vitro and this annotation is an inference (but the FA entry option didn't fit). I would not consider this article alone to be good evidence.
655386119,Genotype TT is associated with decreased risk of side effects when treated with amodiaquine as compared to genotypes CC + CT.,"This is an undetailed review article and the evidence referred to is only in vitro, but I couldn't make the FA entry option work for this. The conclusion is an inference."
655386196,"Genotypes CC + CT are associated with increased risk of reduced response when treated with fluoxetine in people with Depressive Disorder, Major as compared to genotype TT.","Stated as ""suggestive evidence""."
1183689186,CYP2D6 poor metabolizers is not associated with oral clearance or elimination half-life of propranolol when treated with propranolol in healthy individuals as compared to CYP2D6 extensive metabolizer.,
1184136162,"Genotype TT/TT is associated with increased spontaneous HCV clearance in people with Hepatitis C, Chronic as compared to genotype GG.","rs368234815/ss469415590 is more strongly associated with HCV clearance than rs12979860 in individuals of African ancestry, although it provides comparable information in Europeans and Asians."
1184136185,"Genotypes G/TT + GG are associated with increased risk of treatment failure in Japanese patients with with chronic genotype 1 HCV infection when treated with peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to allele TT.",This variant (ss469415590) is in high LD with rs8099917 (r2=0.92) in Japanese.
769146177,"Allele G is associated with severe warfarin resistance, may require a higher dose (INR never reached) when treated with warfarin as compared to allele A.",VKORC1:V45A; Val45Ala
1184136190,"Genotypes GG + GT are associated with increased risk of treatment failure when treated with peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to genotype TT.",in Japanese patients with with chronic genotype 1 HCV infection. This variant (ss469415590) is in high LD with rs8099917 (r2=0.92) in Japanese.
699642298,Genotype AA is associated with decreased major adverse cardiac events (mace) when treated with amlodipine in people with Hypertension as compared to allele G.,and compared to treatment with chlorthalidone. (statistics given for drug comparison)
699642297,Allele G is associated with decreased major adverse cardiac events (mace) when treated with chlorthalidone in people with Hypertension as compared to genotype AA.,and compared to treatment with amlodipine. (statistics given for drug comparison)
699642296,Genotype GG is associated with decreased systolic blood pressure when treated with chlorthalidone in people with Hypertension.,"The variant is actually associated with a GREATER reduction of SBP for chlorthalidone (-6.5 mm Hg) than with amlodipine (-3.8 mm Hg), lisinopril (-2.4 mm Hg), or doxazosin (-3.8 mm Hg)."
655386291,Genotype CC is associated with increased likelihood of nonresponse when treated with paroxetine and sertraline in people with Panic Disorder as compared to genotypes GG + CG.,
655386295,Allele G is associated with increased likelihood of response when treated with antidepressants.,
769143811,"Genotype GG is associated with decreased cardiac rehospitalization when treated with atenolol, Beta Blocking Agents, carvedilol or metoprolol in people with Acute coronary syndrome as compared to genotypes CC + CG.","Patients with the GG genotype who were discharged on various beta blocking agents (including ~66% on metoprolol, ~8% on atenolol and ~6% on carvedilol) had a reduced risk of cardiac rehospitalization."
655387717,Allele T is associated with CYP2C19*17.,
655387742,Genotype TT is associated with decreased AUC of omeprazole in people with no disease as compared to genotype CC.,(significance stated for CYP2C19*17)
655388464,"Allele T is associated with increased risk of Cough when treated with Ace Inhibitors, Plain in people with Hypertension as compared to allele C.",These tendencies were more pronounced in females.
655388472,"Allele T is not associated with increased risk of ACEI-related cough when treated with perindopril in people with Diabetes Mellitus, Type 2 as compared to allele C.",
655388481,"Allele T is not associated with Cough when treated with Ace Inhibitors, Plain in people with Hypertension as compared to allele C.",
655388475,"Genotypes TT + CT are associated with increased risk of Cough when treated with enalapril, imidapril and lisinopril in people with Essential hypertension as compared to genotype CC.",
613977375,Allele G is associated with decreased plasma AUC of pravastatin.,
699638854,Allele T is associated with decreased CYP3A4 acitvity when exposed to rifampin.,
655385847,Allele T is associated with increased risk of Hypertriglyceridemia when treated with ritonavir in people with HIV as compared to allele C.,
769180711,Genotypes CG + GG are associated with decreased Hypertriglyceridemia when treated with protease inhibitors as compared to genotype CC.,"A cross-sectional analysis of race/ethnicity, apoC-III/apoA-I genotypes, and PI exposure on plasma lipids was performed in AIDS Clinical Trial Group studies (n=626). Race/ethnicity was a highly significant predictor of plasma lipids in fully adjusted models. Furthermore, in stratified analyses, the effect of PI exposure appeared to differ across race/ethnicity. Black/non-Hispanic, compared with White/non-Hispanics and Hispanics, had lower plasma triglyceride (TG) levels overall, but the greatest increase in TG levels when exposed to PIs. In Hispanics, current PI antiretroviral therapy exposure was associated with a significantly smaller increase in TGs among patients with variant alleles at apoC-III-482, -455, and Intron 1, or at a composite apoCIII genotype, compared with patients with the wild-type genotypes."
699639387,Genotype AA is associated with decreased HMGCRv_1 expression and an increase in the expression of the full-length transcript as compared to genotypes GG + AG.,in 170 simvastatin-incubated immortalized lymphocyte cell lines derived from participants in the Cholesterol and Pharmacogenetics (CAP) study who were treated with simvastatin 40 mg/d for 6 weeks.
699639419,Allele A is associated with increased residual clearance of intravenous talinolol and lower bioavailablilty of orally administered talinolol when exposed to talinolol as compared to allele G.,
699639424,Genotype CC is associated with increased triglycerides in postmenopausal woman when treated with tamoxifen as compared to genotype TT.,
699639427,Genotype GG is associated with decreased in total cholesterol in postmenopausal woman and increase in triglycerides and decrease in high density lipoprotein in premenopausal women when treated with tamoxifen as compared to genotypes AA + AG.,The decrease in total cholesterol in postmenopausal woman (P=0.03; GG vs GA/AA) and tamoxifen-induced increase in triglycerides (P=0.002; gene-dose effect) and decrease in high density lipoprotein (P=0.004; gene-dose effect) in premenopausal women.
